https://youtu.be/FmwfBTU4jXw Presented by The Mass Tort Institute Hi, my name is Susan and I am the founder and CEO of Case Works. My goal today …

COVID-19’s Impact on the Mass Tort Landscape The mass tort landscape is reaching a new peak while COVID-19 outbreaks and the Delta variant continue to …

Mass tort litigation firms stand to recover large settlement amounts for their clients in mass tort litigation proceedings.

Whether you need to outsource core functions, simple business functions, or just looking for cost savings, outsourcing business processes and operations can benefit all types of law firms.

The mass action litigation against the makers of the popular antacid medication Zantac is still in the early stages. On April 1, 2020, the U.S. Food and Drug Administration (FDA) issued an immediate market withdrawal request of all ranitidine-based medications including Zantac.

DuPont and several related companies have committed $4 billion to cover liabilities stemming from their past use of toxic “forever chemicals” such as PFAS and PFOA. The group of companies also agreed to pay $83 million to settle multidistrict litigation in Ohio to compensate victims harmed by the chemicals.

In mid-November 2020, the U.S. Bankruptcy Court for the Southern District of New York approved a federal settlement agreement valued at $8.3 billion between Purdue Pharma and the Department of Justice (DOJ). As part of the deal, Purdue will plead guilty to 3 felony criminal counts of defrauding the United States.

In two recent rulings, U.S. District Court Judge Robin L Rosenberg dismissed a host of claims against Zantac defendants based on federal pre-emption. In short, preemption is a doctrine that can shield drug manufacturers from liability in certain cases where they follow the FDA requirements for an approved drug or medication.

At its last meeting of 2020, the Judicial Panel on Multidistrict Litigation (JPML) decided to create a new Multidistrict Litigation (MDL) to hear claims filed …

According to complaints filed by plaintiff’s attorneys, Allergan’s misconduct includes using a loophole in the FDAs reporting requirements to hide instances of serious injuries associated …

In a much-anticipated decision, the Judicial Panel on Multidistrict Litigation (JPML) ruled on December 16, 2020 to centralize ParaGard IUD claims against Teva Pharmaceuticals in …

Plaintiffs injured by contaminated valsartan are fighting attempts by Walgreens, CVS and Rite Aid to avoid claims they misrepresented a generic high blood pressure drug …

In a recent court ruling C.R. Bard was told they cannot argue their hernia mesh implant is a “lifesaving device” in the upcoming bellwether trial …

Two years after Bayer A.G. halted sales of Essure in the United States, the company announced it would settle outstanding legal claims for $1.6 billion. …

After years of raking in billions of dollars from its Tenofovir Disoproxil Fumarate (TDF) drug monopoly, Gilead Sciences will have to face competition from the …

Last week, the Missouri Supreme Court shot down Johnson & Johnson’s bid to appeal a $2.1 billion jury verdict in favor of women who blamed …

The FDA continues to recommend manufacturer recalls of the popular diabetes medication metformin after testing shows the presence of a known carcinogen, N-nitrosodimethylamine, more commonly …

On August 20, 2020, Bayer A.G. announced it would pay $1.6 billion to settle Essure claims from women who have been injured by the defective …

On September 29, 2020, the U.S. Food and Drug Administration (FDA) released final labeling recommendations aimed at improving patients’ understanding of the risk associated with …

What is PFAS and Why is it so Dangerous? Simply put, PFAS is class of more than 4,000 different chemicals and turns up in many …